BIOLAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOLAB
Largest movements
- Cash -€302,813
down €302,813 (-36.5%), from €829,745 to €526,932
mainly Receivables within one year (-€242,465) and Contributions, distributions and other (-€238,500)
- Receivables within one year +€242,465
up €242,465 (+3357.7%), from €7,221 to €249,686
of which Trade receivables: +€233,140
- Tangible fixed assets +€44,094
new in 2025: €44,094
- Other debts -€89,382
down €89,382 (-17.2%), from €520,030 to €430,648
- Trade debts +€53,607
up €53,607 (+63.6%), from €84,350 to €137,957
- Debts after one year +€31,593
new in 2025: €31,593
- Tax, wage and social debts -€13,680
down €13,680 (-40.6%), from €33,694 to €20,014
of which Taxes: -€12,804
- Profit (loss) carried forward -€9,955
down €9,955 (-6.1%), from €162,313 to €152,359
- Gross operating margin -€138,569
down €138,569 (-23.9%), from €580,502 to €441,933
- Financial income -€57,106
down €57,106 (-100.0%), from €57,106 to €0
- Taxes -€50,496
down €50,496 (-41.7%), from €121,136 to €70,640
- Financial charges +€16,891
up €16,891, from -€1,315 to €15,576
of which Financial charges: +€9,691
- Staff costs -€9,415
down €9,415 (-7.1%), from €132,972 to €123,557
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €870,295 | €858,980 | -€11,316 | -1.3% |
| Fixed assets | 21/28 | €126 | €48,014 | +€47,887 | +37879.5% |
| Intangible fixed assets | 21 | - | €3,793 | +€3,793 | |
| Tangible fixed assets | 22/27 | - | €44,094 | +€44,094 | |
| Furniture and vehicles | 24 | - | €44,094 | +€44,094 | |
| Financial fixed assets | 28 | €126 | €126 | = | 0.0% |
| Current assets | 29/58 | €870,169 | €810,966 | -€59,203 | -6.8% |
| Stocks and contracts in progress | 3 | €24,434 | €31,355 | +€6,921 | +28.3% |
| Stocks | 30/36 | €24,434 | €31,355 | +€6,921 | +28.3% |
| Amounts receivable within one year | 40/41 | €7,221 | €249,686 | +€242,465 | +3357.7% |
| Trade receivables | 40 | - | €233,140 | +€233,140 | |
| Other amounts receivable | 41 | €7,221 | €16,546 | +€9,325 | +129.1% |
| Cash at bank and in hand | 54/58 | €829,745 | €526,932 | -€302,813 | -36.5% |
| Deferred charges and accrued income | 490/1 | €8,768 | €2,993 | -€5,775 | -65.9% |
| Total equity and liabilities | 10/49 | €870,295 | €858,980 | -€11,316 | -1.3% |
| Equity | 10/15 | €230,484 | €220,529 | -€9,955 | -4.3% |
| Contributions | 10/11 | €61,973 | €61,973 | = | 0.0% |
| Capital | 10 | €61,973 | €61,973 | = | 0.0% |
| Issued capital | 100 | €61,973 | €61,973 | = | 0.0% |
| Reserves | 13 | €6,197 | €6,197 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,197 | €6,197 | = | 0.0% |
| Legal reserve | 130 | €6,197 | €6,197 | = | 0.0% |
| Profit (loss) carried forward | 14 | €162,313 | €152,359 | -€9,955 | -6.1% |
| Amounts payable | 17/49 | €639,811 | €638,450 | -€1,361 | -0.2% |
| Amounts payable after more than one year | 17 | - | €31,593 | +€31,593 | |
| Financial debts | 170/4 | - | €31,593 | +€31,593 | |
| Amounts payable within one year | 42/48 | €638,073 | €596,082 | -€41,992 | -6.6% |
| Current portion of amounts payable after more than one year | 42 | - | €7,463 | +€7,463 | |
| Trade debts | 44 | €84,350 | €137,957 | +€53,607 | +63.6% |
| Suppliers | 440/4 | €84,350 | €137,957 | +€53,607 | +63.6% |
| Taxes, remuneration and social security | 45 | €33,694 | €20,014 | -€13,680 | -40.6% |
| Taxes | 450/3 | €16,136 | €3,332 | -€12,804 | -79.3% |
| Remuneration and social security | 454/9 | €17,558 | €16,682 | -€876 | -5.0% |
| Other amounts payable | 47/48 | €520,030 | €430,648 | -€89,382 | -17.2% |
| Accrued charges and deferred income | 492/3 | €1,738 | €10,776 | +€9,038 | +520.1% |
| Non-recurring operating income | 76A | - | €10,500 | +€10,500 | |
| Remuneration, social security and pensions | 62 | €132,972 | €123,557 | -€9,415 | -7.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,357 | €1,395 | -€3,962 | -74.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €3,652 | - | -€3,652 | |
| Other operating charges | 640/8 | €912 | €2,220 | +€1,308 | +143.5% |
| Gross operating margin | 9900 | €580,502 | €441,933 | -€138,569 | -23.9% |
| Operating profit (loss) | 9901 | €437,610 | €314,761 | -€122,849 | -28.1% |
| Financial income | 75/76B | €57,106 | €0 | -€57,106 | -100.0% |
| Recurring financial income | 75 | €57,106 | €0 | -€57,106 | -100.0% |
| Financial charges | 65/66B | -€1,315 | €15,576 | +€16,891 | |
| Recurring financial charges | 65 | €5,885 | €15,576 | +€9,691 | +164.7% |
| Non-recurring financial charges | 66B | -€7,200 | - | +€7,200 | |
| Profit (loss) for the period before taxes | 9903 | €496,031 | €299,185 | -€196,846 | -39.7% |
| Income taxes | 67/77 | €121,136 | €70,640 | -€50,496 | -41.7% |
| Profit (loss) for the period | 9904 | €374,895 | €228,545 | -€146,350 | -39.0% |
| Profit (loss) for the period to be appropriated | 9905 | €374,895 | €228,545 | -€146,350 | -39.0% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.